Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene, ENSG00000229830, is a pseudogene similar in sequence to a portion of the MT-ND5 gene, which encodes a subunit of mitochondrial complex I (NADH: ubiquinone oxidoreductase)[1][5]. Pseudogenes arise from gene duplication or retrotransposition events but have lost their protein-coding function due to disabling mutations. MTND5P23, as such, does not encode a protein and has no known biological activity, role in disease, or relevance for drug targeting or mechanism-of-action studies[1][5]. It is distinct from the functional mitochondrial gene MT-ND5, which is associated with several mitochondrial diseases[2][3][4], but the pseudogene itself is not biologically or clinically significant. If you are seeking information about the functional mitochondrial gene MT-ND5, it is a core component of complex I in the electron transport chain and is involved in diseases such as MELAS, Leigh syndrome, and Leber hereditary optic neuropathy. However, this pseudogene (ENSG00000229830 / MTND5P23) does not possess those functions and is not a therapeutic target[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of NADH dehydrogenase 5 MTND5.